4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0000947871-21-000053
Options or other derivatives
- Director bought 41,700 shares at $60.00 ($2,502,000)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bonita David P Director | 2021-01-11 | Purchase · Non-Voting Common Stock | +41,700 | $60.00 | $2,502,000 | 5,596,886 | I: show line 1 in the form |
Loading xslF345X03/ownership.xml…